Team:Evry/Achievements

From 2013.igem.org

(Difference between revisions)
 
(24 intermediate revisions not shown)
Line 19: Line 19:
   color: #F5DF00;
   color: #F5DF00;
   padding: 15px;
   padding: 15px;
 +
  font-weight:bold;
}
}
</style>
</style>
Line 28: Line 29:
<div class="jamboree">
<div class="jamboree">
-
   <header>New since European Jamboree!</header>
+
   <header>Since European Jamboree!</header>
   <p>
   <p>
-
<div style="float:left;">
 
-
<img src="https://static.igem.org/mediawiki/2013/7/71/IGEM_Lyon.png" width=200px style="padding: 5px;"/>
 
-
</div>
+
<table>
 +
<tr>
 +
<td>
 +
<img src="https://static.igem.org/mediawiki/2013/7/71/IGEM_Lyon.png" width=200px style="padding: 5px;"/>
 +
</td>
 +
<td>
-
<table border>
+
<table>
<tr>
<tr>
<td colspan=2>
<td colspan=2>
Line 43: Line 47:
<tr>
<tr>
-
<td width=130px>
+
<td width=75px style="vertical-align:top;" >
-
<img src="https://static.igem.org/mediawiki/2013/1/1a/New.png" style="align:center;">
+
<center>
 +
<img src="https://static.igem.org/mediawiki/2013/1/1a/New.png">
 +
</center>
</td>
</td>
<td>
<td>
-
<p>totototootot</p>
+
<p>
 +
<br />
 +
<ul>
 +
<li><b>Biology:</b></li>
 +
  <ul>
 +
      <li>Proceed to new inverter constructions</li>
 +
      <li>Cloned an periplasm located iron chelating protein coming from <i>Nesseria</i></li>
 +
    </ul>
 +
<li><b>Modeling:</b></li>
 +
  <ul>
 +
      <li>We parametrized all our models with the experimental parameters of the iron sensor</li>
 +
      <li>We created a cellular automaton based model of the treatment in the upper intestine</li>
 +
  </ul>
 +
<li><b>Human Practice:</b></li>
 +
  <ul>
 +
      <li>We estimated the cost of the capsule, the benefits for the company producing it and the gain of the French national care system</li>
 +
      <li>We consulted SANOFI, a world leader drug maker</li>
 +
  </ul>
 +
</ul>
 +
 
 +
 
 +
</p>
</td>
</td>
Line 53: Line 80:
<tr>
<tr>
-
<td>
+
<td style="vertical-align:top;">
-
<img src="https://static.igem.org/mediawiki/2013/d/df/Improved.png" align="center">
+
<img src="https://static.igem.org/mediawiki/2013/d/df/Improved.png" align="center" width=81px>
</td>
</td>
<td>
<td>
-
<p>TOTEOTOEIOTIEOIO</p>
+
<p>
 +
<br />
 +
<ul>
 +
  <li><b>Biology:</b></li>
 +
      <ul>
 +
          <li>We improved the characterization of our best iron sensor</li>
 +
      </ul>
 +
  <li><b>Modeling:</b></li>
 +
      <ul>
 +
        <li>We reviewed the math, the code and improved the description of all our models for further re-use in iGEM</li>
 +
      </ul>
 +
  <li><b>Human Practice:</b></li>
 +
      <ul>
 +
            <li>We extended our survey of patient to the rest of the world</li>
 +
      </ul>
 +
<li><b>Wiki:</b></li>
 +
  <ul>
 +
      <li>We made a simplified french version of our Wiki that could be accessible for french patients</li>
 +
      <li>We survived a second Wiki-freeze but without coffee this time !!</li>
 +
  </ul>
 +
 
 +
</ul>
 +
 
 +
</p>
</td>
</td>
Line 63: Line 113:
</table>
</table>
 +
</td>
 +
</table>
    
    

Latest revision as of 03:53, 29 October 2013

Iron coli project

iGEM Evry 2013 achievements


Since European Jamboree!

We worked hard since the last european Jamboree, taking into account the remarks from the juges and continuing on our own ideas. Here are the our main acheivements:


  • Biology:
    • Proceed to new inverter constructions
    • Cloned an periplasm located iron chelating protein coming from Nesseria
  • Modeling:
    • We parametrized all our models with the experimental parameters of the iron sensor
    • We created a cellular automaton based model of the treatment in the upper intestine
  • Human Practice:
    • We estimated the cost of the capsule, the benefits for the company producing it and the gain of the French national care system
    • We consulted SANOFI, a world leader drug maker


  • Biology:
    • We improved the characterization of our best iron sensor
  • Modeling:
    • We reviewed the math, the code and improved the description of all our models for further re-use in iGEM
  • Human Practice:
    • We extended our survey of patient to the rest of the world
  • Wiki:
    • We made a simplified french version of our Wiki that could be accessible for french patients
    • We survived a second Wiki-freeze but without coffee this time !!



Here we detail how we fulfilled each of the iGEM medal requirements.

Gold MedalGold Medal (requires any one of the following goals)

  • We improved the function of an existing BioBrick Part or Device. First, we re-characterize the LacO-RFP BioBrick BBa_J04450 (Biology Results Section) and improve it by integrating it with an aceB-LacI iron sensor (Biobrick BBa_K1163102). Together, these Biobricks create a Fur Inverter (see Biology Results Section) that activates gene expression in response to iron.
  • We collaborated with other iGEM teams: we participated to Purdue and UGent online survey and had a nice workshop with Paris-Saclay team.
    We are also setting up a scientific collaboration with the Edimburgh iGEM team that is working on and environmental sensor using the Fur System.
  • As our project involves treating a human genetic disorder using genetically-engineered bacteria, it has numerous implications for human health, safety and security, and ethics. To enable safe delivery of therapeutic bacteria to the human intestine, we designed and constructed a polymer-based capsule. We also explored safety and ethics consequences of our project as the Human Practices studies:
    1. We discussed the medical feasibility and implications of this treatment in a series of interviews and discussions with renowned experts on iron overload diseases.
    2. We carefully analyzed the safety issues and potential consequences of our bacteria using consequence-based decision tree.
    3. We organized and hosted a scientific conference on iron overload disorders and perceptions of our our project on 18 September 2013. This conference was attended by both medical experts and iron disorder patients.
    4. We prepared and disseminated a patient perception survey about how our treatment could potentially help hemochromatosis patients. We received and analyzed the results from over 250 patients who responded to our survey.
    5. We wrote an extensive report on our conclusions about synthetic biology , which is the fruit of our many discussions over the summer.

Silver MedalSilver Medal (requires each of the four following goals)


Bronze MedalBronze Medal (requires each of the five following goals)

  • We registered our team for iGEM 2013 and are attending the European Regional Jamboree.
  • We completed and submitted the Judging form.
  • We made a comprehensive and accessible iGEM Evry 2013 Wiki to convey our educational and scientific advances.
  • We will present a poster and give an oral presentation at the iGEM European Jamboree in Lyon, France.
  • We document 22 BioBricks used in our project and submit 8 news BioBricks to the Parts Registry (see 8 submitted Biobricks in Silver Medal Requirements).